B. Riley Securities Maintains Buy on Nakamoto, Raises Price Target to $13
B. Riley Securities Maintains Buy on Nakamoto, Raises Price Target to $11
Nakamoto CEO David Bailey Says Bitcoin’s Corporate Turn Isn’t A ‘Betrayal’ – Eyes Bigger Push Into M&A
Nakamoto Q2 EPS $(6.56) Misses $(0.60) Estimate, Sales $35.869M Beat $9.422M Estimate
TD Cowen Maintains Buy on Nakamoto, Raises Price Target to $17
Why is Nakamoto (NAKA) stock surging on July 15?
Nasdaq-listed firm makes a drastic move to go all in on Bitcoin
Nakamoto Shuts Its Last Healthcare Clinics to Go All-In on Bitcoin
Nakamoto Shuts Down Healthcare Clinics; Completes Transition To Bitcoin-Focused Media And Financial Services Business Model
Insider Stock Buying Of Nakamoto Delivers Return On US$992.6k Investment
Nakamoto Announces 1-For-40 Reverse Stock Split
Nakamoto Q2 EPS $(0.38) Misses $0.01 Estimate, Sales $2.678M Miss $13.633M Estimate
Nakamoto Announces Details Of Actively-Managed Bitcoin Derivatives Program Aimed At Capturing Volatility Income And Hedge Downside BTC Exposure
TD Cowen Initiates Coverage On Nakamoto with Buy Rating, Announces Price Target of $1
Nakamoto Files Shelf Prospectus Of Offering For Up To $7B Of Securities
Maxim Group Maintains Buy on Nakamoto, Lowers Price Target to $0.75
Nakamoto Q4 EPS $0.07 Beats $(0.01) Estimate, Sales $444.924K Beat $400.000K Estimate
Cohen & Company: Has The Market Gone Too Far?
All You Need to Know About KindlyMD, Inc. (NAKA) Rating Upgrade to Buy
Here's Why KindlyMD, Inc. (NAKA) is Poised for a Turnaround After Losing 41.5% in 4 Weeks
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.